Structure-activity relationship studies of 3-aroylindoles as potent antimitotic agents

被引:45
作者
Liou, Jing-Ping
Mahindroo, Neeraj
Chang, Chun-Wei
Guo, Fu-Ming
Lee, Sandy Wen-Hsing
Tan, Uan-Kang
Yeh, Teng-Kuang
Kuo, Ching-Chuan
Chang, Yi-Wei
Lu, Ping-Hsun
Tung, Yen-Shih
Lin, Ke-Ta
Chang, Jang-Yang
Hsieh, Hsing-Pang
机构
[1] Division of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Zhunan, Miaoli County 350
[2] College of Pharmacy, Taipei Medical University
[3] Institute of Cancer Research, National Health Research Institutes
[4] Department of Chemical Engineering, Northern Taiwan Institute of Science and Technology
关键词
Antitumor agents; Indoles; Pharmacokinetics; Structure-activity Relationships; Tubulin;
D O I
10.1002/cmdc.200600125
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The concise synthesis and structure-activity relationship (SAR) studies of 3-aroylindoles were carried out in an effort to improve the potency and solubility of anticancer drug candidate BPR0L075 (8) by exploring structure modifications through three regimens: substitution of the B ring, at the N1 position, and of the 3-carbonyl linker. The SAR information revealed that the methoxy group of the Bring could be replaced with an electron-donating group such as methyl (in compound 9) or N,N-dimethylamino (in compound 13) while retaining both strong cytotoxic and antitubulin activities. The introduction of amide (compounds 30-33) and carbamate (compounds 34-37) functionalities at the N1 position of 8 gave analogues with potent antiproliferative activities. The cytotoxic potency of 8 was improved by replacing the carbonyl group with sulfide (compound 41) or oxygen (compound 43), indicating that the carbonyl moiety is important but not essential. The N,N-dimethylamino derivative 13 not only displayed potent cytotoxicity and antitubulin activity, but also showed a markedly improved physicochemical profile relative to the parent compound.
引用
收藏
页码:1106 / 1118
页数:13
相关论文
共 19 条
[1]   SYNTHESIS OF INDOLES VIA RING-CLOSURE OF 2-ALKYLNITROANILINE DERIVATIVES [J].
BERGMAN, J ;
SAND, P .
TETRAHEDRON, 1990, 46 (17) :6085-6112
[2]   Effects of indole fatty alcohols on the differentiation of neural stem cell derived neurospheres [J].
Coowar, D ;
Bouissac, J ;
Hanbali, M ;
Paschaki, M ;
Mohier, E ;
Luu, B .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (25) :6270-6282
[3]   SYNTHESIS AND EVALUATION OF STILBENE AND DIHYDROSTILBENE DERIVATIVES AS POTENTIAL ANTICANCER AGENTS THAT INHIBIT TUBULIN POLYMERIZATION [J].
CUSHMAN, M ;
NAGARATHNAM, D ;
GOPAL, D ;
CHAKRABORTI, AK ;
LIN, CM ;
HAMEL, E .
JOURNAL OF MEDICINAL CHEMISTRY, 1991, 34 (08) :2579-2588
[4]  
Davis PD, 2002, CANCER RES, V62, P7247
[5]   Arylthioindoles, potent inhibitors of tubulin polymerization [J].
De Martino, G ;
La Regina, G ;
Coluccia, A ;
Edler, MC ;
Barbera, MC ;
Brancale, A ;
Wilcox, E ;
Hamel, E ;
Artico, M ;
Silvestri, R .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (25) :6120-6123
[6]   Pharmaceutical design of antimitotic agents based on combretastatins [J].
Hsieh, HP ;
Liou, JP ;
Mahindroo, N .
CURRENT PHARMACEUTICAL DESIGN, 2005, 11 (13) :1655-1677
[7]   Structure-activity and crystallographic analysis of benzophenone derivatives - the potential anticancer agents [J].
Hsieh, HP ;
Liou, JP ;
Lin, YT ;
Mahindroo, N ;
Chang, JY ;
Yang, YN ;
Chern, SS ;
Tan, UK ;
Chang, CW ;
Chen, TW ;
Lin, CH ;
Chang, YY ;
Wang, CC .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (01) :101-105
[8]   BPR0L075, a novel synthetic indole compound with antimitotic activity in human cancer cells, exerts effective antitumoral activity in vivo [J].
Kuo, CC ;
Hsieh, HP ;
Pan, WY ;
Chen, CP ;
Lion, JP ;
Lee, SJ ;
Chang, YL ;
Chen, LT ;
Chen, CT ;
Chang, JY .
CANCER RESEARCH, 2004, 64 (13) :4621-4628
[9]   Discovery and development of antimitotic agents that inhibit tubulin polymerisation for the treatment of cancer [J].
Li, Q ;
Sham, HL .
EXPERT OPINION ON THERAPEUTIC PATENTS, 2002, 12 (11) :1663-1702
[10]   Concise synthesis and structure-activity relationships of combretastatin A-4 analogues, 1-aroylindoles and 3-aroylindoles, as novel classes of potent antitubulin agents [J].
Liou, JP ;
Chang, YL ;
Kuo, FM ;
Chang, CW ;
Tseng, HY ;
Wang, CC ;
Yang, YN ;
Chang, JY ;
Lee, SJ ;
Hsieh, HP .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (17) :4247-4257